Xenetic Biosciences, Inc. (XBIOW)
Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.
Address
945 CONCORD ST.
FRAMINGHAM, MA 01701
Founded
2011
Number of Employees
4
Website
http://www.xeneticbio.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)